The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Research Report 2024
Synopsis
Anaplastic Lymphoma Kinase (ALK) gene, as a tyrosine kinase closely related to tumors, can be activated by translocation or mutation. Abnormal expression such as gene mutation, rearrangement and amplification can activate cell signal transduction in the body. Pathway, which regulates the growth, differentiation and migration of tumors. Tyrosine kinases are kinases that enzymatically catalyze the transfer of gamma phosphate groups from adenosine triphosphate to target proteins. They can catalyze the phosphorylation of protein tyrosine residues on a variety of substrates, and play an important role in cell growth, proliferation, and differentiation. The main oncology indications for tyrosine kinase inhibitors (TKI) include solid tumors and leukemia.
The global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) in Leukemia is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) include Pfizer, Nuvartis, Takeda, Betta Pharma, Shouyao Holding and Chugai Pharmaceutical Co, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ALK Tyrosine Kinase Inhibitors (ALK-TKIs).
Report Scope
The ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ALK Tyrosine Kinase Inhibitors (ALK-TKIs) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Nuvartis
Takeda
Betta Pharma
Shouyao Holding
Chugai Pharmaceutical Co
Segment by Type
Crizotinib
Alectinib
Ceritinib
Brigatinib
Lorlatinib
Ensartinib
CT-707
Segment by Application
Leukemia
Solid Tumor
Lung Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Anaplastic Lymphoma Kinase (ALK) gene, as a tyrosine kinase closely related to tumors, can be activated by translocation or mutation. Abnormal expression such as gene mutation, rearrangement and amplification can activate cell signal transduction in the body. Pathway, which regulates the growth, differentiation and migration of tumors. Tyrosine kinases are kinases that enzymatically catalyze the transfer of gamma phosphate groups from adenosine triphosphate to target proteins. They can catalyze the phosphorylation of protein tyrosine residues on a variety of substrates, and play an important role in cell growth, proliferation, and differentiation. The main oncology indications for tyrosine kinase inhibitors (TKI) include solid tumors and leukemia.
The global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) in Leukemia is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) include Pfizer, Nuvartis, Takeda, Betta Pharma, Shouyao Holding and Chugai Pharmaceutical Co, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ALK Tyrosine Kinase Inhibitors (ALK-TKIs).
Report Scope
The ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ALK Tyrosine Kinase Inhibitors (ALK-TKIs) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Nuvartis
Takeda
Betta Pharma
Shouyao Holding
Chugai Pharmaceutical Co
Segment by Type
Crizotinib
Alectinib
Ceritinib
Brigatinib
Lorlatinib
Ensartinib
CT-707
Segment by Application
Leukemia
Solid Tumor
Lung Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Crizotinib
1.2.3 Alectinib
1.2.4 Ceritinib
1.2.5 Brigatinib
1.2.6 Lorlatinib
1.2.7 Ensartinib
1.2.8 CT-707
1.3 Market by Application
1.3.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Leukemia
1.3.3 Solid Tumor
1.3.4 Lung Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Perspective (2019-2030)
2.2 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Growth Trends by Region
2.2.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Historic Market Size by Region (2019-2024)
2.2.3 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecasted Market Size by Region (2025-2030)
2.3 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Dynamics
2.3.1 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Industry Trends
2.3.2 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Drivers
2.3.3 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Challenges
2.3.4 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Players by Revenue
3.1.1 Global Top ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Players by Revenue (2019-2024)
3.1.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Players (2019-2024)
3.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue
3.4 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Concentration Ratio
3.4.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in 2023
3.5 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Key Players Head office and Area Served
3.6 Key Players ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Solution and Service
3.7 Date of Enter into ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Breakdown Data by Type
4.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Historic Market Size by Type (2019-2024)
4.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecasted Market Size by Type (2025-2030)
5 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Breakdown Data by Application
5.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Historic Market Size by Application (2019-2024)
5.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size (2019-2030)
6.2 North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2019-2024)
6.4 North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size (2019-2030)
7.2 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2019-2024)
7.4 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size (2019-2030)
8.2 Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2019-2024)
8.4 Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size (2019-2030)
9.2 Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2019-2024)
9.4 Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size (2019-2030)
10.2 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2019-2024)
10.4 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Introduction
11.1.4 Pfizer Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Nuvartis
11.2.1 Nuvartis Company Detail
11.2.2 Nuvartis Business Overview
11.2.3 Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Introduction
11.2.4 Nuvartis Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024)
11.2.5 Nuvartis Recent Development
11.3 Takeda
11.3.1 Takeda Company Detail
11.3.2 Takeda Business Overview
11.3.3 Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Introduction
11.3.4 Takeda Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024)
11.3.5 Takeda Recent Development
11.4 Betta Pharma
11.4.1 Betta Pharma Company Detail
11.4.2 Betta Pharma Business Overview
11.4.3 Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Introduction
11.4.4 Betta Pharma Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024)
11.4.5 Betta Pharma Recent Development
11.5 Shouyao Holding
11.5.1 Shouyao Holding Company Detail
11.5.2 Shouyao Holding Business Overview
11.5.3 Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Introduction
11.5.4 Shouyao Holding Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024)
11.5.5 Shouyao Holding Recent Development
11.6 Chugai Pharmaceutical Co
11.6.1 Chugai Pharmaceutical Co Company Detail
11.6.2 Chugai Pharmaceutical Co Business Overview
11.6.3 Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Introduction
11.6.4 Chugai Pharmaceutical Co Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024)
11.6.5 Chugai Pharmaceutical Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Crizotinib
Table 3. Key Players of Alectinib
Table 4. Key Players of Ceritinib
Table 5. Key Players of Brigatinib
Table 6. Key Players of Lorlatinib
Table 7. Key Players of Ensartinib
Table 8. Key Players of CT-707
Table 9. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Region (2019-2024)
Table 13. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Region (2025-2030)
Table 15. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Trends
Table 16. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Drivers
Table 17. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Challenges
Table 18. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Restraints
Table 19. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Players (2019-2024)
Table 21. Global Top ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) as of 2023)
Table 22. Ranking of Global Top ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product Solution and Service
Table 26. Date of Enter into ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Type (2019-2024)
Table 30. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Type (2025-2030)
Table 32. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Application (2019-2024)
Table 34. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Application (2025-2030)
Table 36. North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2025-2030) & (US$ Million)
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product
Table 54. Pfizer Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Nuvartis Company Detail
Table 57. Nuvartis Business Overview
Table 58. Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product
Table 59. Nuvartis Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024) & (US$ Million)
Table 60. Nuvartis Recent Development
Table 61. Takeda Company Detail
Table 62. Takeda Business Overview
Table 63. Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product
Table 64. Takeda Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. Betta Pharma Company Detail
Table 67. Betta Pharma Business Overview
Table 68. Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product
Table 69. Betta Pharma Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024) & (US$ Million)
Table 70. Betta Pharma Recent Development
Table 71. Shouyao Holding Company Detail
Table 72. Shouyao Holding Business Overview
Table 73. Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product
Table 74. Shouyao Holding Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024) & (US$ Million)
Table 75. Shouyao Holding Recent Development
Table 76. Chugai Pharmaceutical Co Company Detail
Table 77. Chugai Pharmaceutical Co Business Overview
Table 78. Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product
Table 79. Chugai Pharmaceutical Co Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024) & (US$ Million)
Table 80. Chugai Pharmaceutical Co Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Type: 2023 VS 2030
Figure 3. Crizotinib Features
Figure 4. Alectinib Features
Figure 5. Ceritinib Features
Figure 6. Brigatinib Features
Figure 7. Lorlatinib Features
Figure 8. Ensartinib Features
Figure 9. CT-707 Features
Figure 10. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Application: 2023 VS 2030
Figure 12. Leukemia Case Studies
Figure 13. Solid Tumor Case Studies
Figure 14. Lung Cancer Case Studies
Figure 15. Others Case Studies
Figure 16. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Report Years Considered
Figure 17. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Region: 2023 VS 2030
Figure 20. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Players in 2023
Figure 21. Global Top ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in 2023
Figure 23. North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Country (2019-2030)
Figure 25. United States ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Country (2019-2030)
Figure 29. Germany ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Region (2019-2030)
Figure 37. China ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Country (2019-2030)
Figure 45. Mexico ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Country (2019-2030)
Figure 49. Turkey ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Pfizer Revenue Growth Rate in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024)
Figure 52. Nuvartis Revenue Growth Rate in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024)
Figure 53. Takeda Revenue Growth Rate in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024)
Figure 54. Betta Pharma Revenue Growth Rate in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024)
Figure 55. Shouyao Holding Revenue Growth Rate in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024)
Figure 56. Chugai Pharmaceutical Co Revenue Growth Rate in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
